SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000921895-18-001809
Filing Date
2018-05-24
Accepted
2018-05-24 17:25:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO THE SCHEDULE 13D sc13da111643003_05242018.htm SC 13D/A 46441
2 COMPLAINT exato13da111643003_05242018.htm EX-99.A 91602
  Complete submission text file 0000921895-18-001809.txt   139380
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Subject) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87471 | Film No.: 18858858
SIC: 2834 Pharmaceutical Preparations

Mailing Address 140 SUNHAVEN CLOSE SE CALGARY A0 T2X 2V9
Business Address
Sorenson Bradley T. (Filed by) CIK: 0001728512 (see all company filings)

Type: SC 13D/A